Eyelid, Conjunctival and Orbital Tumors
Normal Price: £359.00
Discount Code: ESCRS15
Authors:Carol L Shields and Jerry A. Shields
“Written by world-renowned authorities in ocular oncology at the Wills Eye Institute, these two text/atlases provide a complete pictorial and textual guide to the clinical features, pathology, diagnosis, and management of eyelid, conjunctival, orbital, and intraocular tumors and pseudotumors. The two books contain over 4,800 photographs and surgical drawings—more than 4,200 in full color—that depict the clinical variations, histopathologic characteristics, and treatment of all neoplasms and related lesions. The Second Edition of Eyelid, Conjunctival, and Orbital Tumors: An Atlas and Text combines the content of Atlas of Eyelid and Conjunctival Tumors and Atlas of Orbital Tumors. The Second Edition of Intraocular Tumors: An Atlas and Text provides greatly expanded coverage of benign and malignant lesions that affect the uveal tract, retina, and other intraocular structures. Both volumes are thoroughly updated and contain over 50 percent new material.
Each entity is presented in an easy-to-follow format: a concise description with references on the left-hand page and six illustrations on the right-hand page. The photographs show in precise detail the gross and microscopic features that distinguish each type of lesion. Professional drawings and intraoperative photographs demonstrate key surgical principles and procedures.”Back to previous
All books available to purchase on the wisepress platform. Please apply code ESCRS15 when making your purchase to claim the 15% discount. Discounts ONLY available via online portal.
About Education Portal
With our new range of online resources, you can continue your education year-round with ESCRS.
All of our resources together in one place:
iLearn, On Demand, Player, Landmark Journal Articles, Case Studies, Course Handouts and more…
- Rethinking astigmatism analysis for intraocular lens-based surgery (Also contains link to download Astigmatism Double Angle Plot Tool) May 27, 2019
- Similar five-year results with SMILE and FS-LASIK May 27, 2019
- Triamcinolone acetate reduces CME after cataract surgery in diabetic patients but bevacizumab has no additive effect-PREMED Study May 27, 2019
ESCRS Education PortalTemple House,
Temple Road, Blackrock,
Co Dublin, Ireland
Phone: +35312091100 Email: email@example.com